Citric Acid

Citric Acid

SCHEMBL5839170

O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O.O=C(O)CC(O)(CC(=O)O)C(=O)O.[NaH].[NaH].[NaH]

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2

The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ MEN1 known ✓ O00255 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.94
▸ HMGCR P04035 1/20 0.48
▸ CHRM1 P11229 1/20 0.48
▸ TBXA2R P21731 1/20 0.48
▸ ADRA1A P35348 1/20 0.48
▸ TSHR P16473 2/20 0.46
▸ CYP2D6 P10635 2/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ HIF1A Q16665 1/20 0.46
▸ ACLY P53396 4/20 0.44
▸ KDM4E B2RXH2 2/20 0.43
▸ LMNA P02545 2/20 0.43
▸ MAPT P10636 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ SLC13A5 Q86YT5 4/20 0.42
▸ CPT2 P23786 1/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Citric Acid SCHEMBL8400312 1.00 ALDH1A1 (0.94) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
Citric Acid SCHEMBL4819877 1.00 ALDH1A1 (0.94) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
Citric Acid SCHEMBL3659 1.00 ALDH1A1 (0.94) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
Citric Acid SCHEMBL11211773 1.00 ALDH1A1 (0.94) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
Citric Acid SCHEMBL9070187 1.00 ALDH1A1 (0.94) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
Citric Acid SCHEMBL2593972 1.00 ALDH1A1 (0.94) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
Citric Acid SCHEMBL4372285 1.00 ALDH1A1 (0.94) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
Citric Acid SCHEMBL116215 1.00 ALDH1A1 (0.94) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
Citric Acid SCHEMBL11519286 1.00 ALDH1A1 (0.94) ALDH1A1HMGCRCHRM1TBXA2RADRA1A
Citric Acid SCHEMBL2411531 1.00 ALDH1A1 (0.94) ALDH1A1HMGCRCHRM1TBXA2RADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117124459-A Preparation method of stain-resistant antibacterial lightweight concrete external wall panel 南昌工学院 2023-11-28 — — CN claimed
CN-107522929-A A kind of anlistatig high polymer material 南通成山高分子材料有限公司 2017-12-29 — — CN claimed
CN-105542520-B It is a kind of for antirust coat of base steel material and preparation method thereof 上海底特精密紧固件股份有限公司 2017-10-24 — — CN claimed
CN-106818791-A A kind of emamectin-benzoate mite killing suspending agent of eugenol synergy and preparation method thereof 孙华飞 2017-06-13 — — CN claimed
CN-106631408-A Pest-resistant high-yielding and high-efficiency corn fertilizer and preparation method thereof 新昌县老五农产品专业合作社 2017-05-10 — — CN claimed
CN-106635495-A Antibacterial hand-protective hand-wash liquid detergent and preparation method thereof 苏州纳贝通环境科技有限公司 2017-05-10 — — CN claimed
CN-117124459-A Preparation method of stain-resistant antibacterial lightweight concrete external wall panel 南昌工学院 2023-11-28 — — CN disclosed
CN-107522929-A A kind of anlistatig high polymer material 南通成山高分子材料有限公司 2017-12-29 — — CN disclosed
CN-106818791-A A kind of emamectin-benzoate mite killing suspending agent of eugenol synergy and preparation method thereof 孙华飞 2017-06-13 — — CN disclosed
US-7153649-B2 Treatment of congestive heart failure VASOGEN IRELAND LIMITED (IE) 2006-12-26 — — US disclosed
US-20060193835-A1 Treatment of congestive heart failure SMITH ELDON R 2006-08-31 — — US disclosed
EP-1267897-B1 TREATMENT OF CONGESTIVE HEART FAILURE BY PRETREATED AUTOLOGOUS BLOOD VASOGEN IRELAND LTD (IE) 2004-11-10 — — EP disclosed
US-6572895-B2 Treating an aliquot of patient's blood ex vivo with a stressor selected from temperature above or below body temperature, an electromagnetic emission and an oxidative environment, followed by administering back into patient VASOGEN IRELAND LIMITED (IE) 2003-06-03 — — US disclosed
US-20030044390-A1 Treatment of congestive heart failure VASOGEN IRELAND LIMITED (IE) 2003-03-06 — — US disclosed
EP-1267897-A1 TREATMENT OF CONGESTIVE HEART FAILURE BY PRETREATED AUTOLOGOUS BLOOD Vasogen Ireland Limited (IE) 2003-01-02 — — EP disclosed
US-20020051766-A1 Treatment of congestive heart failure VASOGEN IRELAND LIMITED (IE) 2002-05-02 — — US disclosed
WO-2001052870-A1 TREATMENT OF CONGESTIVE HEART FAILURE BY PRETREATED AUTOLOGOUS BLOOD VASOGEN IRELAND LIMITED (IE) 2001-07-26 — — WO disclosed
Send feedback